34.50
전일 마감가:
$33.75
열려 있는:
$34
하루 거래량:
203.46K
Relative Volume:
0.28
시가총액:
$1.51B
수익:
$596.57M
순이익/손실:
$-109.88M
주가수익비율:
-8.9044
EPS:
-3.8741
순현금흐름:
$28.72M
1주 성능:
+4.44%
1개월 성능:
-7.76%
6개월 성능:
+70.86%
1년 성능:
+9.93%
Azenta Inc Stock (AZTA) Company Profile
명칭
Azenta Inc
전화
(978) 262-2400
주소
200 SUMMIT DRIVE, BURLINGTON
Compare AZTA vs ISRG, BDX, RMD, ALC, MDLN
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
AZTA
Azenta Inc
|
34.48 | 1.35B | 596.57M | -109.88M | 28.72M | -3.8741 |
|
ISRG
Intuitive Surgical Inc
|
401.91 | 130.41B | 11.03B | 3.16B | 3.22B | 8.7251 |
|
BDX
Becton Dickinson Co
|
181.78 | 48.44B | 21.37B | 1.41B | 3.07B | 3.9437 |
|
RMD
Resmed Inc
|
224.78 | 31.49B | 5.54B | 1.52B | 1.74B | 10.37 |
|
ALC
Alcon Inc
|
65.52 | 31.92B | 10.63B | 819.00M | 1.59B | 1.6577 |
|
MDLN
Medline Inc
|
33.65 | 28.54B | 29.14B | 1.07B | 1.05B | 1.1956 |
Azenta Inc Stock (AZTA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-05 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2025-12-19 | 재확인 | Needham | Buy |
| 2025-10-30 | 업그레이드 | Jefferies | Hold → Buy |
| 2025-08-06 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2025-07-22 | 재개 | Stephens | Equal-Weight |
| 2024-12-18 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2024-04-04 | 개시 | Jefferies | Hold |
| 2024-02-01 | 재확인 | B. Riley Securities | Buy |
| 2023-07-19 | 개시 | Raymond James | Mkt Perform |
| 2023-05-10 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-02-09 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2023-01-03 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2022-03-31 | 재개 | B. Riley Securities | Buy |
| 2022-03-21 | 개시 | Evercore ISI | Outperform |
모두보기
Azenta Inc 주식(AZTA)의 최신 뉴스
Azenta, Inc. (AZTA) accounting chief reports owning no stock - Stock Titan
Azenta (NASDAQ: AZTA) Secures Early $35M Vendor Loan Repayment, Finalizing $63M Cash Purchase - Kalkine Media
Azenta Completes B Medical Divestiture With Loan Repayment - theglobeandmail.com
Azenta Secures Full $35M Vendor Loan Repayment from B Medical Buyer Ahead of Schedule - Kalkine Media
Azenta completes B Medical sale as vendor loan repaid (AZTA) - Seeking Alpha
Azenta receives full $35M vendor loan repayment, completing $63M sale of B Medical Systems. - Pluang
Azenta Receives Full $35 Million Vendor Loan Repayment From B Medical Sale - citybiz
Azenta receives full $35.37M repayment, completes $63M sale of B Medical Systems - TradingView
Azenta Receives Full Repayment of $35 Million Vendor Loan Related to Sale of B Medical Systems - PR Newswire
A $63 million sale is now fully paid in cash. Azenta received the final $35 million. - Stock Titan
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Azenta, Inc.AZTA - PR Newswire
How Investors Are Reacting To Azenta (AZTA) CEO Resignation And Interim Leadership Change - simplywall.st
Azenta CEO Resigns as Interim Leader Reassures Outlook - theglobeandmail.com
Why Azenta (AZTA) Stock Is Down Today - Barchart.com
Azenta CEO John Marotta Steps Down; Dr. Martin Madaus Named Interim CEO - Kalkine Media
Azenta appoints interim CEO as John Marotta resigns By Investing.com - Investing.com Nigeria
Azenta Names Martin Madaus Interim CEO, Reaffirms Revenue Guidance - citybiz
AZENTA ANNOUNCES LEADERSHIP TRANSITION - marketscreener.com
ETFs Investing in Azenta, Inc. Stocks - TradingView
Azenta (AZTA) Results Check: EPS Beats Its Estimate for the Current Session; Price Move: Shares Move Lower 1.79% in the Available RecordNew Analyst Coverage - vinanet.vn
Azenta, Inc. Earnings Call Balances Growth And Strain - theglobeandmail.com
Azenta, Inc.: Financial Data Forecasts Estimates and Expectations | BA3 | US1143401024 - marketscreener.com
Azenta: Needs To Overcome A Few Hurdles If The Rally Is To Continue (NASDAQ:AZTA) - Seeking Alpha
AZTA Q2 2026 Earnings: EPS Surpasses Estimates by 37.8% on Operational StrengthReturn On Equity - vinanet.vn
Azenta, Inc. (AZTA) Stock Forecasts - Yahoo Finance
Azenta Inc. (AZTA) Edges Higher to $33.53 as Life Sciences Tools Sector StabilizesExhaustion Gap - vinanet.vn
The 5 Most Interesting Analyst Questions From Azenta’s Q2 Earnings Call - Yahoo! Finance Canada
Azenta (AZTA) Is Up 11.5% After Returning To Profit And Raising Revenue OutlookHas The Bull Case Changed? - webull.com
Azenta (AZTA) SVP Pirogova has 1,085 shares withheld for tax obligations - Stock Titan
Azenta, Inc. Announces Appointment of Erik J. Bello as Chief Accounting Officer, Effective August 31, 2026 - marketscreener.com
Azenta, Inc. (AZTA) Stock Analysis: Navigating Growth in the Healthcare Sector with a 4.41% Potential Upside - DirectorsTalk Interviews
Azenta (AZTA) Holds Steady at $33.39 as Shares Trade Mid-Range Between Support and ResistancePCR Moving Average - vinanet.vn
Weekly Recap: Azenta, Inc. Q3 revenue gain and analyst target raises - TradingView
Azenta Inc (AZTA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Securities Fraud Investigation Into Azenta, Inc. (AZTA) Continues - The National Law Review
Azenta Inc (AZTA) Stock News Today - TradingKey
Azenta, Inc. $AZTA Stake Cut by Quantinno Capital Management LP - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Is Investigating Azenta, Inc. (AZTA) And Encourages Investors to Connect - The National Law Review
Azenta (AZTA) Is Up 6.7% After Raising 2026 Guidance And Completing $50M Buyback – What’s Changed - Yahoo Finance
Multi-Manager Small Cap Equity Strategies Fund's Azenta Inc(AZTA) Holding History - GuruFocus
Azenta, Inc. 3Q 2026: Revenue $161.18M, EPS $0.05— 10-Q Summary - TradingView
Azenta (Nasdaq: AZTA) sells B Medical unit, books $149M impairment - Stock Titan
Life Science Funding Weakness Hit Azenta’s (AZTA) Outlook - Yahoo Finance
Azenta, Inc. $AZTA Shares Sold by Bank of New York Mellon Corp - MarketBeat
Arrowstreet Capital Limited Partnership Buys New Position in Azenta, Inc. $AZTA - MarketBeat
Azenta (AZTA) Drops 3%: Approaching Key Support at $29.33 Amid Sector HeadwindsIchimoku Entry - vinanet.vn
Azenta Inc (AZTA) (Q3 2026) Earnings Call Highlights: Organic Gr - GuruFocus
Azenta, Inc. Stock 12‑Month Price Target Raised to $33.8, Implies 12% Upside - TradingView
Azenta Inc (AZTA) (Q3 2026) Earnings Call Highlights: Organic Growth Surges 9% Amid Strategic ... - Yahoo Finance
Azenta Releases Q3 2026 Financial Results - AlphaStreet
Azenta (NASDAQ:AZTA) Price Target Raised to $37.00 - MarketBeat
Azenta Inc (AZTA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Azenta Inc 주식 (AZTA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Cornog William L | Director |
May 18 '26 |
Buy |
16.38 |
10,000 |
163,800 |
19,703 |
자본화:
|
볼륨(24시간):